Evidence map›Paper›PMID 40671551›Full record

ArticleProtein science : a publication of the Protein Society2025

Predicting interacting hotspots for nanobodies' binding using triplets of residues.

Rahma Hamdani, Damiano Cianferoni, Raul Reche, Javier Delgado, Luis Serrano

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Predicting interacting hotspots for nanobodies' binding using triplets of residues.Protein science : a publication of the Protein Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rahma HamdaniDepartment of Systems and Synthetic Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0009-0002-3654-0378
Damiano CianferoniDepartment of Systems and Synthetic Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0003-0702-2758
Raul RecheDepartment of Systems and Synthetic Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0002-0210-9144
Javier DelgadoDepartment of Systems and Synthetic Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0003-1302-5445
Luis SerranoDepartment of Systems and Synthetic Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0002-5276-1392

Funding

European Commission Via Horizon 2020 101020135Ministry Of Science and Innovation and Universities, The State Research Agency and The European Social Fund Plus PRE 2022-101389Ministry of Science, Innovation and Universities, The State Research Agency and The European Regional Development Fund PID2021-122341NB-I00Research Foundation Flanders (FWO) S000722N
6 · The paper itself

Abstract

Protein-protein interactions (PPI) are fundamental to cellular signaling, forming robust networks that govern critical biological processes such as immune response, cell growth, and signal transduction. Nanobody-based therapies have emerged as a key strategy for modulating PPIs, offering exceptional potential due to their high specificity, stability, and ability to access challenging epitopes on PPI interfaces inside cells. The rational design of nanobodies relies mainly on understanding and predicting their binding regions, particularly the residues that contribute the most to the binding energy (binding hotspots). Existing computational methods do not fully provide a scalable solution for hotspot identification in nanobody design, leaving a critical gap in the rational design of these therapeutics. Here, we present a scalable and structure-aware algorithm for hotspot prediction in nanobody design. The algorithm queries a curated database of triplets of interacting residues obtained from ~20,000 non-redundant PDB structures. We showed that these triplets contain structural and energetic information, being able to assess the stability effect of residue variations in protein structures, Pearson R = 0.63 (MSE = 1.58 kcal/mol). More important than effects on stability is the ability of the algorithm to predict binding hotspots of protein-protein generic complexes and more specifically in complexes containing nanobodies. HotspotPred reached an accuracy of 0.73 for hotspot residue identification in a protein interaction dataset of 1160 Alanine mutants and correctly identified in 63.4% of the cases we predicted at least 2 residues on the binding surface.

Indexed as

AlgorithmsSingle-Domain AntibodiesBinding SitesDatabases, ProteinHumansProtein BindingSingle-Domain Antibodiesbinding hotspotscomputational predictiondrug discoverynanobodiesprotein–protein interactionsstructural biology

Identifiers

PMID40671551
PMCPMC12268110

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.